Swiss private bank Julius Baer has identified a breakthrough that could reshape the future of cancer care and open up compelling long-term investment opportunities for ultra high net worth (UHNW) clients. The technology known as liquid biopsy is emerging as a game-changer in diagnostics, offering earlier and more accurate detection of cancer compared to traditional methods. Speaking to Asian Private…